All PlansCoverageMedium impact
New policies
Blue Cross Blue Shield of Rhode Island·RI · Pulmonology, Infectious Disease, Internal Medicine +1 more·Physician / Facility
We identified it
Jun 19, 2026
Summary
BCBS Rhode Island has created two new medical policies: one covering Envisia testing for Idiopathic Pulmonary Fibrosis and another covering COVID-19 Monoclonal Antibody Treatment. The billing team must review the full policy text on the provider website to understand coverage criteria and billing requirements, as effective dates vary by policy.
Action Required
Immediately: Billing team must access bcbsri.com Provider section under Medical Policy heading to review full text of both new policies (Envisia for Idiopathic Pulmonary Fibrosis and COVID-19 Monoclonal Antibody Treatment). Note the specific effective dates and coverage criteria for each policy. Update billing protocols and prior authorization requirements as specified in the complete policy documents.